85907857 - UNIQURE

Information

• Trademark
• 85907857

• Source

• Serial Number

  85907857

• Registration Number

  4710280

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  April 18, 2013
  11 years ago

• Registration Date

  March 31, 2015
  9 years ago

• Transaction Date

  October 04, 2024
  2 months ago

• Status Date

  April 01, 2021
  3 years ago

• Published for Opposition Date

  September 02, 2014
  10 years ago

• Location Date

  April 01, 2021
  3 years ago

• Status Code

  705

• Employee Name

  LEVINE, HOWARD

• Attorney Docket Number

  140998-00101

  Attorney Name

  Zachary A. Aria

  Law Office Assigned Location Code

  M60

• Owners

  • uniQure IP B.V.

Case File Statements

• GS0051: Viral medicines, gene therapy medicines, nucleic acid delivery medicines, viral vectors, [non-viral vectors,] gene therapy vectors, nucleic acid delivery vectors, [and cells transformed by viral vectors, non-viral vectors, gene therapy vectors and nucleic acid delivery vectors] for medical purposes all for medical treatment of metabolic disorders, [ocular disorders,] diseases of the nervous system, blood disorders, liver disorders, [muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases,] inherited disorders, genetic disorders, single gene disorders [and cancers;] pharmaceutical preparations and substances for the treatment of metabolic disorders, [ocular disorders,] diseases of the nervous system, blood disorders, liver disorders, [muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases,] inherited disorders, genetic disorders, single gene disorders [and cancers;] biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy [and cell therapy,] all for the treatment of metabolic disorders, [ocular disorders,] diseases of the nervous system, blood disorders, liver disorders, [muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases,]inherited disorders, genetic disorders, single gene disorders [and cancers;] [clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing in the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases, inherited disorders, genetic disorders, single gene disorders and cancers; pharmaceutical preparations, vaccines, prophylaxis medicines and other] pharmaceutical preparations [all] for use in nucleic acid-based therapy, gene therapy [and cell therapy] in the treatment of metabolic disorders, [ocular disorders,] diseases of the nervous system, blood disorders, liver disorders, [muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases,] inherited disorders, genetic disorders, single gene disorders [and cancers]
• CC0000: Color is not claimed as a feature of the mark.
• GS0011: [Viral assays, viral reagents, viral preparations, gene therapy assays, gene therapy reagents, gene therapy preparations, nucleic acid delivery assays, nucleic acid delivery reagents, nucleic acid delivery preparations, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors and nucleic acid delivery vectors, all for non-medical research purposes]
• GS0441: Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, [ocular disorders,] diseases of the nervous system, blood disorders, liver disorders, [muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders,] inherited disorders, genetic disorders and single gene disorders
• GS0421: Research, product development and consultancy in the field of biotechnology, biologics, pharmaceutics, medical science, chemistry and biochemistry

Case File Event Statements

• 8/5/2013 - 11 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 4/22/2013 - 11 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 4/25/2013 - 11 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 8/5/2013 - 11 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 8/5/2013 - 11 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/5/2013 - 11 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 7/24/2014 - 10 years ago

  15 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 1/16/2014 - 10 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/16/2014 - 10 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/26/2014 - 10 years ago

  9 - ASSIGNED TO LIE Type: ALIE

• 1/31/2014 - 10 years ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/31/2014 - 10 years ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/22/2014 - 10 years ago

  12 - FINAL REFUSAL WRITTEN Type: CNFR

• 2/22/2014 - 10 years ago

  13 - FINAL REFUSAL E-MAILED Type: GNFR

• 2/22/2014 - 10 years ago

  14 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 10/29/2014 - 10 years ago

  26 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN

• 7/24/2014 - 10 years ago

  16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/24/2014 - 10 years ago

  17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/28/2014 - 10 years ago

  18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 7/28/2014 - 10 years ago

  19 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 8/13/2014 - 10 years ago

  20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 9/2/2014 - 10 years ago

  21 - PUBLISHED FOR OPPOSITION Type: PUBO

• 9/2/2014 - 10 years ago

  22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 10/28/2014 - 10 years ago

  23 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 10/29/2014 - 10 years ago

  24 - TEAS DELETE 1(B) BASIS RECEIVED Type: D1BR

• 11/18/2014 - 10 years ago

  27 - 1(B) BASIS DELETED; PROCEED TO REGISTRATION Type: DP1B

• 11/18/2014 - 10 years ago

  25 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 3/31/2015 - 9 years ago

  28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 3/31/2020 - 4 years ago

  29 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1

• 9/17/2020 - 4 years ago

  30 - TEAS SECTION 8 & 15 RECEIVED Type: E815

• 11/10/2020 - 4 years ago

  31 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 4/1/2021 - 3 years ago

  32 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15P

• 4/1/2021 - 3 years ago

  33 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85

• 3/31/2024 - 8 months ago

  34 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2

• 10/4/2024 - 2 months ago

  35 - TEAS SECTION 8 & 9 RECEIVED Type: E89R